225 related articles for article (PubMed ID: 31999044)
1. Improvement in Quality of Life and Decrease in Large-Volume Paracentesis Requirements With the Automated Low-Flow Ascites Pump.
Wong F; Bendel E; Sniderman K; Frederick T; Haskal ZJ; Sanyal A; Asrani SK; Capel J; Kamath PS
Liver Transpl; 2020 May; 26(5):651-661. PubMed ID: 31999044
[TBL] [Abstract][Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
3. Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.
Bureau C; Adebayo D; Chalret de Rieu M; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rosi S; MacDonald S; Malago M; Stepanova M; Younossi ZM; Trepte C; Watson R; Borisenko O; Sun S; Inhaber N; Jalan R
J Hepatol; 2017 Nov; 67(5):940-949. PubMed ID: 28645737
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory ascites with an automated low-flow ascites pump in patients with cirrhosis.
Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Stallmach A; Engelmann C; Trepte C; Capel J; De Gottardi A
Aliment Pharmacol Ther; 2017 Nov; 46(10):981-991. PubMed ID: 28940225
[TBL] [Abstract][Full Text] [Related]
5. Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.
Stepanova M; Nader F; Bureau C; Adebayo D; Elkrief L; Valla D; Peck-Radosavljevic M; McCune A; Vargas V; Simon-Talero M; Cordoba J; Angeli P; Rossi S; MacDonald S; Capel J; Jalan R; Younossi ZM
Qual Life Res; 2018 Jun; 27(6):1513-1520. PubMed ID: 29460201
[TBL] [Abstract][Full Text] [Related]
6. Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump.
Stirnimann G; Berg T; Spahr L; Zeuzem S; McPherson S; Lammert F; Storni F; Banz V; Babatz J; Vargas V; Geier A; Engelmann C; Herber A; Trepte C; Capel J; De Gottardi A
Liver Int; 2022 Oct; 42(10):2247-2259. PubMed ID: 35686702
[TBL] [Abstract][Full Text] [Related]
7. Automated low flow pump system for the treatment of refractory ascites: a single-center experience.
Thomas MN; Sauter GH; Gerbes AL; Stangl M; Schiergens TS; Angele M; Werner J; Guba M
Langenbecks Arch Surg; 2015 Dec; 400(8):979-83. PubMed ID: 26566989
[TBL] [Abstract][Full Text] [Related]
8. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
9. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
Neong SF; Adebayo D; Wong F
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
[TBL] [Abstract][Full Text] [Related]
10. Current treatment options of refractory ascites in liver cirrhosis - A systematic review and meta-analysis.
Will V; Rodrigues SG; Berzigotti A
Dig Liver Dis; 2022 Aug; 54(8):1007-1014. PubMed ID: 35016859
[TBL] [Abstract][Full Text] [Related]
11. [Management of refractory ascites by the automated low flow pump system (Alfapump)].
Restellini S; Soares PC; Giostra E; Spahr L
Rev Med Suisse; 2014 Sep; 10(440):1607-8, 1610-1. PubMed ID: 25276999
[TBL] [Abstract][Full Text] [Related]
12. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
13. Automated low-flow ascites pump in a real-world setting: complications and outcomes.
Solbach P; Höner Zu Siederdissen C; Wellhöner F; Richter N; Heidrich B; Lenzen H; Kerstin P; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1082-1089. PubMed ID: 29738325
[TBL] [Abstract][Full Text] [Related]
14. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
[TBL] [Abstract][Full Text] [Related]
15. Management of refractory ascites.
Wong F
Clin Mol Hepatol; 2023 Jan; 29(1):16-32. PubMed ID: 35676862
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
17. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Transjugular Intrahepatic Portosystemic Shunt versus Large-Volume Paracentesis in Refractory Ascites: Results of a Markov Model Incorporating Individual Patient-Level Meta-Analysis and Nationally Representative Cost Data.
Kwan SW; Allison SK; Gold LS; Shin DS
J Vasc Interv Radiol; 2018 Dec; 29(12):1705-1712. PubMed ID: 30392803
[TBL] [Abstract][Full Text] [Related]
19. Current management of refractory ascites in patients with cirrhosis.
Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
[TBL] [Abstract][Full Text] [Related]
20. First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan.
Tsuruya K; Koizumi J; Sekiguchi Y; Ono S; Sekiguchi T; Hara T; Mishima Y; Arase Y; Hirose S; Shiraishi K; Kagawa T
BMJ Open Gastroenterol; 2023 Apr; 10(1):. PubMed ID: 37085275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
